Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Organic Standards
  6. Folinic acid calcium salt hydrate, ≥90%, MilliporeSigma™ Supelco™

Folinic acid calcium salt hydrate, ≥90%, MilliporeSigma™ Supelco™

Catalog No. 111013181 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
100 mg
500 mg
1 g
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-3181 100 mg
11-101-3179 500 mg
11-101-3180 1 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Catalog No. 11-101-3181 Supplier MilliporeSigma Supelco Supplier No. F7878100MG
Only null left
Add to Cart
Add to Cart

Description

Folinic acid calcium salt hydrate is a drug, widely used for the treatment of cancer, since it can reduce toxic side effects and helps to improve drug accumulation in tumor tissues.

Featured Industries: Pharmaceutical (small molecule)
TRUSTED_SUSTAINABILITY

Specifications

CAS 1492-18-8 (anhydrous)
Physical Form Neat
Linear Formula C20H21 CaN7O7 · xH2 O
Melting Point 240°C to 250°C
Synonym 5-Formyl-5,6,7,8-tetrahydrofolic acid calcium salt; 5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid calcium salt; 5-HCO-H4 PteGlu; Calcium folinate; Citrovorum factor calcium salt; Leucovorin calcium salt
Type Analytical Standard
Quantity 100 mg
Formula Weight 511.50 (anhydrous basis)
Percent Purity ≥90%
Grade Analytical Standard
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.